Therapy of Parkinson
Kaeser, H.E.
Schweizerische Rundschau für Medizin Praxis 70(50): 2247-2249
1981
ISSN/ISBN: 1013-2058 PMID: 7312828 Document Number: 177007
Document emailed within 1 workday
Related Documents
Clarenbach, P.; Fröscher, W. 1986: Therapy of Parkinson syndrome Fortschritte der Medizin 104(44): 857-861Umbach, W. 1970: Classification and therapy of the Parkinson syndrome Deutsche Medizinische Wochenschrift 95(1): 44-45
Roth, J.; Růzicka, E.; Kanovský, P. 2000: Advance in therapy Parkinson's disease Vnitrni Lekarstvi 46(11): 811-816
Nau, J.-Y. 2014: Parkinson: the latest results of gene therapy Revue Medicale Suisse 10(414): 202-203
Bhat, V.; Weiner, W.J. 2005: Parkinson's disease. Diagnosis and the initiation of therapy Minerva Medica 96(3): 145-154
Adams, K.T. 2015: Therapy for Parkinson's psychosis closer to market Managed Care 24(2): 16-17
Ransmayr, G.; Jeschow, M. 1995: Future aspects of modern Parkinson therapy Wiener Medizinische Wochenschrift 145(13): 299-301
Birkmayer, W. 1987: Milestones in the development of modern Parkinson therapy Journal of Neural Transmission. Supplementum 25: 1-3
Lombardo, L. 1974: Recent advances in the therapy of Parkinson's syndrome Gaceta Medica de Mexico 107(6): 513-524
1998: Cabergolin: new horizons in the therapy of Parkinson diseases Der Nervenarzt 69(9 Suppl Neue Horiz): 1-8
Ludin, H.P. 1984: Long-term therapy of the Parkinson syndrome Schweizerische Medizinische Wochenschrift 114(33): 1131-1136
Pfeiffer, C.; Wagner, M.L. 1994: Clozapine therapy for Parkinson's disease and other movement disorders American Journal of Hospital Pharmacy 51(24): 3047-3053
Chase, T.N.; Baronti, F.; Fabbrini, G.; Heuser, I.J.; Juncos, J.L.; Mouradian, M.M. 1989: Rationale for continuous dopaminomimetic therapy of Parkinson's disease Neurology 39(11 Suppl 2: 7
Horisberger, J.D. 2000: Placebo surgery in trials of therapy for Parkinson's disease New England Journal of Medicine 342(5): 354-355
Slattery, J. 2000: Placebo surgery in trials of therapy for Parkinson's disease New England Journal of Medicine 342(5): 354; Author Reply 355
Möller, J.C.; Sautter, J.; Kupsch, A. 1996: Potential of neurotrophic factors in therapy of Parkinson's disease Journal of Neural Transmission. Supplementum 48: 103-112
Mera, S.L. 1996: Parkinson's disease: prospects for prevention and improved therapy British Journal of Biomedical Science 53(3): 177-178
Gehlen, W. 1980: Adverse effects of drug therapy in Parkinson disease Medizinische Monatsschrift für Pharmazeuten 3(4): 104-110
Ginath, Y.; Lavy, S.; Abramsky, O.; Carmon, A. 1971: Mental complications of L-dopa therapy in Parkinson's patients Israel Annals of Psychiatry and Related Disciplines 9(3): 252-264
Pacchetti, C.; Aglieri, R.; Mancini, F.; Martignoni, E.; Nappi, G. 1998: Active music therapy and Parkinson's disease: methods Functional Neurology 13(1): 57-67